Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;36(9):1632-1640.
doi: 10.1111/jdv.18190. Epub 2022 May 21.

Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas

Affiliations

Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas

A Plana-Pla et al. J Eur Acad Dermatol Venereol. 2022 Sep.

Abstract

Background: Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are common and may provide useful diagnostic and prognostic information, but they have not been widely studied.

Objectives: To characterize cutaneous lesions in a Spanish cohort of patients with NF2 and investigate associations with clinical and genetic severity.

Methods: We studied the clinical and histologic characteristics of cutaneous lesions in 49 patients with NF2 and analysed correlations with phenotype- and genotype-based severity scores. We collected information on the presence/absence of cutaneous lesions, location, age at onset, type of lesion, and histologic features. We also studied level of systemic involvement and genetic mutations involved.

Results: Forty-nine patients (31 women [63.3%] and 18 men [36.7%]) were analysed, and 33 (67.3%) had cutaneous lesions presumed to be schwannomas. According to their clinical form, they were distributed as follows: 24 patients (48%) had deep tumours, 21 (42%) had plaque-like lesions, and 3 (6%) had superficial tumours. Histologic examination from 27 lesions analysed out 23 patients showed classic schwannoma or hybrid schwannoma-neurofibroma features in the 8 deep tumours biopsied and plexiform schwannoma features in the 17 plaque-like lesions and the 2 superficial tumours analysed. Early onset (first 2 decades of life) was reported by all patients with plaques and superficial tumours. In our cohort, 100% of the patients with plaque-like lesions and superficial tumours with microscopic features of plexiform schwannoma were in the 2 groups with the most severe clinical phenotypes, and 82.6% of them were in the 3 most severe genotype-based classes.

Conclusions and relevance: Cutaneous lesions, specially plexiform schwannomas, are common in NF2, and they usually appear at an early age providing useful diagnostic and prognostic information. These tumours are part of the spectrum of cutaneous manifestations in this disease. Although its diagnostic and prognostic value has been pointed out, there are few studies focussed on their analysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Deep schwannoma, located on the wrist of a patient with NF2. (b and c) Plaque‐like plexiform schwannoma, defined as soft, slightly raised, roughened lesions with hypertrichosis and a darker colour than the surrounding skin, in a patient with NF2. (d) Plexiform schwannoma characterized by bundles of spindle cells surrounded by a thin fibrous capsule in the superficial dermis. The cells are positive for s‐100. (e) Superficial schwannoma in a patient with NF2. [Colour figure can be viewed at wileyonlinelibrary.com]

Similar articles

References

    1. Evans DG. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 2009; 4: 16. - PMC - PubMed
    1. Asthagiri AR, Parry DM, Butman JA et al. Neurofibromatosis type 2. Lancet 2009; 373: 1974. - PMC - PubMed
    1. Selvanathan SK, Shenton A, Ferner R et al. Further genotype‐phenotype correlations in neurofibromatosis 2. Clin Genet 2010; 77: 163. - PubMed
    1. Smith MJ, Higgs JE, Bowers NL et al. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet 2011; 48: 261–265. - PubMed
    1. Hexter A, Jones A, Joe H et al. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UKnational analysis of 1192 patients. J Med Genet 2015; 52: 699–705. - PubMed